eCommons

 

2019 CVM News: Cancer and SIRT5

dc.contributor.authorOffice of Marketing and Communications. Media Relations
dc.date.accessioned2019-07-12T17:52:51Z
dc.date.available2019-07-12T17:52:51Z
dc.date.issued2019-05-30
dc.description.abstractThis news item from Cornell Research is about: New anticancer agents are in great demand due to the heterogeneous nature of cancer and the development of resistance to existing drugs. This collaborative research with Robert Weiss, Biomedical Sciences, Richard Cerione, Molecular Medicine, and Hening Lin, Chemistry and Chemical Biology, aims to establish SIRT5 inhibition as new strategy to treat cancers.
dc.identifier.urihttps://hdl.handle.net/1813/66698
dc.language.isoen_US
dc.publisherCornell University. College of Veterinary Medicine
dc.subjectCornell University. College of Veterinary Medicine -- Periodicals.
dc.subjectWeiss, Robert
dc.subjectCerione, Richard
dc.subjectCornell Research
dc.title2019 CVM News: Cancer and SIRT5
dc.title.alternative2019 CVM News: Weiss, Cerione to study the detailed molecular functions of SIRT5 in cancer cells with $1.95M NIH grant
dc.typearticle

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
CVM-News_2019_May_30_Cancer.pdf
Size:
816.14 KB
Format:
Adobe Portable Document Format